Inspiring new hope
Driven by a passion to make a lasting, positive impact on global health, FloraWorks is unlocking the untapped potential of cannabinoids to improve lives.
We stand at the forefront of cannabinoid science, pioneering the discovery and development of rare and novel cannabinoid-based therapeutics that offer new possibilities for wellness and medicine.













Our vision
At FloraWorks, we believe non-intoxicating cannabinoids belong on the shelves of mainstream health and wellness retailers backed by gold-standard scientific validation.
We are reshaping perceptions through evidence: proving efficacy and safety with the same rigor used in pharmaceutical and dietary ingredient development.
Our work is guided by a single belief: when science meets purpose, new hope emerges for people whose needs have not been met by conventional medicine.
Our research & development
The gold standard of manufacturing excellence.
Quality management you can rely on
Peer-reviewed, published research from a 1000+ person cohort.
Validated toxicology and stability testing.
Guided by experts
TruCBN™ is supported by a Scientific Advisory Board spanning sleep medicine, clinical development and cannabinoid science. They help shape our research priorities, review emerging data and guide the scientific direction of TruCBN™.

Anne Marie Morse, DO, FAASM
CLINICAL SLEEP ADVISOR
Board-certified neurologist and sleep medicine specialist who leads Child Neurology and Pediatric Sleep Medicine at Geisinger.

Judi Profant, PhD
SLEEP SCIENCE & CLINICAL DEVELOPMENT ADVISOR
Clinical psychologist and behavioral sleep medicine specialist with extensive CNS drug-development experience across Janssen, Jazz, Teva and Supernus.

Mike McCormick, PhD
TRANSLATIONAL SCIENCE ADVISOR
MIT-trained chemist and former Scripps cannabinoid researcher specializing in cannabinoid biochemistry and translational science.
Leading through Science

Peer-reviewed clinical trial · Pharmaceuticals, 2024
TruCBN™ Randomized Controlled Sleep Trial
Read the study →

Real-world evidence · People Science
TruCBN™ People Science Real-World Sleep Study
Read the study →

Real-world evidence · MoreBetter
TruCBN™ MoreBetter 21-Night Sleep Study
Read the study →

Preclinical research · Salk Institute
CBN and Age-Related Cognitive Decline
Read the study →
From our CEO
By advancing our understanding of cannabinoids and their interaction with human biology, we can unlock
a new class of therapeutic ingredients
. Our mission is to translate that science into accessible wellness solutions that contribute to a healthier, more hopeful world.
Redefining wellness
Find out how non-intoxicating cannabinoids could revolutionize the supplement industry.

FloraWorks in the News
Stay ahead in the world of cannabinoid science
Join our exclusive email list for the latest insights and breakthroughs.




